Duck embryo vaccine
Purified Duck embryo vaccine (PDEV) was the first vaccine developed for human use in treating pre- and postexposure to the rabies virus. It was developed in 1957 and was made of dried, killed rabies virus. Vaccination with DEV involved a series of intradermal injections over several days. The World Health Organization still includes DEV in its list of recommended vaccines for treatment of rabies virus exposure. However, newer vaccines are more commonly used. These include the human diploid cell vaccine (HDCV) first introduced in 1978; purified chicken embyro cell vaccine (PCECV), developed in 1984; and a purified Vero cell rabies vaccine (PVCRV) developed in 1986. [1][2][3]
See also
References
- ↑ Keller H, Glueck R, Wegmann A et al. Immunogenicity of a New, Highly Purified, Highly Concentrated Duck Embryo Rabies Vaccine. Schweiz med Wschr 1984; 114:648-653
- ↑ Glueck R, Wegmann A, Germanier R et al. A New, Highly Immunogenic Duck Embryo Rabies Vaccine. The Lancet 1984; April 14: 844.
- ↑ Centers for Disease Control Morbidity and Mortality Weekly Report. Atlanta. January 08, 1999 /48(RR-1);1-21
External links
- Vaccines and Antisera at DMOZ
- WHO Vaccine preventable diseases and immunization
- The History of Vaccines, from the College of Physicians of Philadelphia
- University of Oxford Vaccinology Programme: a series of short courses in vaccinology
This article is issued from Wikipedia - version of the 2/21/2014. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.